As of 2025-10-28, the Intrinsic Value of Biovaxys Technology Corp (BIOV.CN) is -1.03 CAD. This BIOV.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.29 CAD, the upside of Biovaxys Technology Corp is -454.99%.
Based on its market price of 0.29 CAD and our intrinsic valuation, Biovaxys Technology Corp (BIOV.CN) is overvalued by 454.99%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.03 - -1.03 | -1.03 | -454.99% |
| P/E | (0.01) - 0.10 | 0.06 | -78.7% |
| DDM - Stable | (4.10) - 115.82 | 55.86 | 19161.2% |
| DDM - Multi | (2.73) - 59.37 | (5.69) | -2063.5% |
| Market Cap (mil) | 8.51 |
| Beta | 0.20 |
| Outstanding shares (mil) | 29.34 |
| Enterprise Value (mil) | 8.64 |
| Market risk premium | 5.10% |
| Cost of Equity | 5.68% |
| Cost of Debt | 5.00% |
| WACC | 5.66% |